Caribou Biosciences Inc (CRBU)

$2.49 -0.01 (-0.40%)
Market Cap 231.88M
Revenue (ttm) 9.99M
Net Income (ttm) -149.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,492.59%
Debt to Equity Ratio 0.00
Volume 656,700
Avg Vol 1,052,722
Day's Range N/A - N/A
Shares Out 93.12M
Stochastic %K 31%
Beta 2.59
Analysts Strong Sell
Price Target $8.86

Company Profile

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 982 6030
Address:
2929 7th Street, Suite 105, Berkeley, United States
josegodoy
josegodoy Oct. 25 at 11:30 AM
$CRBU I can’t wait to see this data
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:26 PM
$CRBU i ❤️ python
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:25 PM
$CRBU
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:25 PM
$CRBU
0 · Reply
L2Lurker
L2Lurker Oct. 23 at 2:42 PM
$GTIM alright I’m taking the 100% gains here. Not sure how far it’ll pullback so I gotta lock the profits. $CRBU is next. $2 calls with 1/16/26 expiry. Gonna pay 100% minimum
0 · Reply
deaccord
deaccord Oct. 23 at 12:14 AM
$CRBU Bought more on this dip,
1 · Reply
Strangperson
Strangperson Oct. 22 at 9:23 PM
$CRBU
0 · Reply
Ewak21
Ewak21 Oct. 22 at 3:30 PM
$CRBU Nooooooo
0 · Reply
Bojack_money
Bojack_money Oct. 21 at 4:07 PM
$CRBU Shorts are dead. Long live the bull run! Christmas is paid for....now go to $10 and get me a boat! (CEO already stated Pfizer would not buy for $1B...SO technically $10 is out of the question....$PFE will purchase in the $4-8 range imo...all depending on how good the news is for the two trials)
5 · Reply
Swing22
Swing22 Oct. 21 at 1:06 PM
$CRBU $10
0 · Reply
Latest News on CRBU
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Aug 25, 2025, 4:05 PM EDT - 2 months ago

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 12, 2025, 4:05 PM EDT - 2 months ago

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

May 28, 2025, 4:00 PM EDT - 5 months ago

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 4:05 PM EDT - 6 months ago

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

May 6, 2025, 4:00 PM EDT - 6 months ago

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Apr 24, 2025, 4:15 PM EDT - 6 months ago

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Apr 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Apr 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Apr 6, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 3, 2025, 10:00 AM EDT - 7 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 7 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Mar 30, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Mar 27, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Mar 25, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Mar 20, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Mar 18, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 16, 2025, 10:00 AM EDT - 7 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Mar 13, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Mar 11, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 10, 2025, 4:05 PM EDT - 8 months ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Feb 24, 2025, 5:45 AM EST - 8 months ago

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 23, 2025, 9:27 AM EST - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

Feb 20, 2025, 1:28 PM EST - 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 19, 2025, 10:22 AM EST - 8 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Caribou Biosciences to Participate in Upcoming Investor Conferences

Feb 18, 2025, 4:05 PM EST - 8 months ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

Feb 15, 2025, 3:04 PM EST - 9 months ago

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Jan 29, 2025, 10:51 AM EST - 9 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

Jan 12, 2025, 7:05 PM EST - 10 months ago

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 4:00 PM EST - 10 months ago

Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

josegodoy
josegodoy Oct. 25 at 11:30 AM
$CRBU I can’t wait to see this data
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:26 PM
$CRBU i ❤️ python
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:25 PM
$CRBU
0 · Reply
RocroBio
RocroBio Oct. 23 at 9:25 PM
$CRBU
0 · Reply
L2Lurker
L2Lurker Oct. 23 at 2:42 PM
$GTIM alright I’m taking the 100% gains here. Not sure how far it’ll pullback so I gotta lock the profits. $CRBU is next. $2 calls with 1/16/26 expiry. Gonna pay 100% minimum
0 · Reply
deaccord
deaccord Oct. 23 at 12:14 AM
$CRBU Bought more on this dip,
1 · Reply
Strangperson
Strangperson Oct. 22 at 9:23 PM
$CRBU
0 · Reply
Ewak21
Ewak21 Oct. 22 at 3:30 PM
$CRBU Nooooooo
0 · Reply
Bojack_money
Bojack_money Oct. 21 at 4:07 PM
$CRBU Shorts are dead. Long live the bull run! Christmas is paid for....now go to $10 and get me a boat! (CEO already stated Pfizer would not buy for $1B...SO technically $10 is out of the question....$PFE will purchase in the $4-8 range imo...all depending on how good the news is for the two trials)
5 · Reply
Swing22
Swing22 Oct. 21 at 1:06 PM
$CRBU $10
0 · Reply
OverTheShoulderBagHolder
OverTheShoulderBagHolder Oct. 21 at 2:55 AM
$CRBU not sure of this has been posted https://news.bloomberglaw.com/securities-law/caribou-biosciences-shareholders-drop-executive-board-lawsuit
2 · Reply
RocroBio
RocroBio Oct. 20 at 7:51 PM
$ABCL $CRBU $CRSP $EDIT
0 · Reply
RocroBio
RocroBio Oct. 20 at 6:36 PM
$CRBU 💪🏼💪🏼
1 · Reply
NicaInvest85
NicaInvest85 Oct. 20 at 2:23 PM
$CRBU keep buying- is just the beginning. I will come back to talk to you all when $CRBU hits $6
0 · Reply
RocroBio
RocroBio Oct. 19 at 7:44 PM
$CRBU anyone else realize the ex Chief Patent Officer for Pfizer is now on the board at Caribou. Dara Richardson-Heron
2 · Reply
RocroBio
RocroBio Oct. 18 at 7:39 PM
$CRBU some interesting job openings on LinkedIn
2 · Reply
RocroBio
RocroBio Oct. 18 at 7:37 PM
$CRBU
0 · Reply
RocroBio
RocroBio Oct. 18 at 7:34 PM
$CRBU
0 · Reply
RocroBio
RocroBio Oct. 18 at 7:32 PM
$CRBU $PFE
0 · Reply
RocroBio
RocroBio Oct. 18 at 7:32 PM
$CRBU
0 · Reply
RocroBio
RocroBio Oct. 18 at 7:31 PM
$CRBU
0 · Reply
josegodoy
josegodoy Oct. 18 at 2:22 PM
$CRBU
1 · Reply